JP2017523152A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017523152A5 JP2017523152A5 JP2016574454A JP2016574454A JP2017523152A5 JP 2017523152 A5 JP2017523152 A5 JP 2017523152A5 JP 2016574454 A JP2016574454 A JP 2016574454A JP 2016574454 A JP2016574454 A JP 2016574454A JP 2017523152 A5 JP2017523152 A5 JP 2017523152A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- pharmaceutically acceptable
- acceptable salt
- stereoisomer
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462017201P | 2014-06-25 | 2014-06-25 | |
| US62/017,201 | 2014-06-25 | ||
| PCT/US2015/037812 WO2015200709A1 (en) | 2014-06-25 | 2015-06-25 | Histone demethylase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017523152A JP2017523152A (ja) | 2017-08-17 |
| JP2017523152A5 true JP2017523152A5 (oth) | 2018-08-09 |
| JP6521535B2 JP6521535B2 (ja) | 2019-05-29 |
Family
ID=54929774
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016574454A Active JP6521535B2 (ja) | 2014-06-25 | 2015-06-25 | ヒストンデメチラーゼ阻害剤 |
Country Status (29)
| Country | Link |
|---|---|
| US (7) | US9242968B2 (oth) |
| EP (3) | EP3738960A1 (oth) |
| JP (1) | JP6521535B2 (oth) |
| KR (1) | KR102591897B1 (oth) |
| CN (2) | CN106660982B (oth) |
| AR (1) | AR100997A1 (oth) |
| AU (1) | AU2015279719B2 (oth) |
| BR (1) | BR112016030367A2 (oth) |
| CA (1) | CA2953437C (oth) |
| CL (1) | CL2016003301A1 (oth) |
| CO (1) | CO2017000359A2 (oth) |
| CY (1) | CY1123906T1 (oth) |
| DK (1) | DK3160952T3 (oth) |
| EA (1) | EA031200B1 (oth) |
| EC (1) | ECSP17004931A (oth) |
| ES (1) | ES2862648T3 (oth) |
| HR (1) | HRP20210299T1 (oth) |
| HU (1) | HUE053876T2 (oth) |
| IL (1) | IL249629A0 (oth) |
| LT (1) | LT3160952T (oth) |
| MX (1) | MX375219B (oth) |
| NZ (1) | NZ728120A (oth) |
| PL (1) | PL3160952T3 (oth) |
| PT (1) | PT3160952T (oth) |
| SA (1) | SA516380585B1 (oth) |
| SG (1) | SG11201610813TA (oth) |
| SI (1) | SI3160952T1 (oth) |
| TW (2) | TWI715533B (oth) |
| WO (1) | WO2015200709A1 (oth) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014100818A1 (en) | 2012-12-21 | 2014-06-26 | Quanticel Pharmaceuticals, Inc. | Histone demethylase inhibitors |
| AR100997A1 (es) | 2014-06-25 | 2016-11-16 | Quanticel Pharmaceuticals Inc | Derivados de piridina como inhibidores de histona demetilasa |
| US9643965B2 (en) | 2014-09-17 | 2017-05-09 | Celgene Quantical Research, Inc. | Histone demethylase inhibitors |
| US10030017B2 (en) | 2014-09-17 | 2018-07-24 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| EP3397617A4 (en) * | 2015-12-28 | 2019-05-22 | Celgene Quanticel Research, Inc. | HISTONDEMETHYLASEINHIBITOREN |
| JP6970681B2 (ja) * | 2016-03-15 | 2021-11-24 | セルジーン クオンティセル リサーチ，インク． | ヒストンデメチラーゼ阻害剤 |
| US10150754B2 (en) | 2016-04-19 | 2018-12-11 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| US20200039938A1 (en) * | 2017-03-30 | 2020-02-06 | Albert-Ludwigs-University Freiburg | Kdm4 inhibitors |
| CN109825551B (zh) * | 2019-02-21 | 2022-08-02 | 深圳大学 | 一种评价组蛋白赖氨酸去甲基转移酶活性的方法 |
| CN111679072B (zh) * | 2020-06-15 | 2022-04-29 | 温州医科大学 | Kdm6b蛋白在乳腺癌预后评估试剂盒、诊断试剂盒中的应用 |
| WO2022217100A1 (en) * | 2021-04-09 | 2022-10-13 | Tachyon Therapeutics, Inc. | Treatment of cancer with kdm4 inhibitors |
| CA3227684A1 (en) * | 2021-08-18 | 2023-02-23 | Jr. Richard M. Heid | Process for preparing histone demethylase inhibitors |
| CA3242035A1 (en) * | 2021-12-23 | 2023-06-29 | Gowri Sukumar | Pharmaceutical formulations comprising 3-({[(4r)-7-{methyl[4-(propan-2-yl)phenyl]amino}-3,4-dihydro-2h-l-benzopyran-4-yl]methyl}amino)pyridine-4-carboxylic acid |
| AR129578A1 (es) | 2022-06-10 | 2024-09-11 | Forward Therapeutics Inc | MODULADORES DE LA ACTIVIDAD DE TNF-a |
| US20250241905A1 (en) * | 2022-06-23 | 2025-07-31 | The Cleveland Clinic Foundation | 3-beta-hsd1 inhibitors and compositions and uses thereof |
| CN120225189A (zh) * | 2022-09-21 | 2025-06-27 | 细胞基因公司 | 组蛋白去甲基化酶抑制剂3-({[(4r)-7-{甲基[4-(丙烷-2-基)苯基]氨基}-3，4-二氢-2h-1-苯并吡喃-4-基]甲基}氨基)吡啶-4-甲酸l-赖氨酸盐的结晶形式 |
| CN115974647B (zh) * | 2022-12-05 | 2024-09-03 | 江苏宏邦化工科技有限公司 | 以四氢-4-甲基-2-苯基-2h-吡喃-4-醇为原料制备苯乐戊醇的方法 |
| WO2025085527A1 (en) * | 2023-10-16 | 2025-04-24 | The Cleveland Clinic Foundation | 3βHSD1 INHIBITORS AND COMPOSITIONS AND USES THEREOF |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1429765A2 (en) | 2001-09-14 | 2004-06-23 | Methylgene, Inc. | Inhibitors of histone deacetylase |
| UA89035C2 (ru) | 2003-12-03 | 2009-12-25 | Лео Фарма А/С | Эфиры гидроксамовых кислот и их фармацевтическое применение |
| DE102004039876A1 (de) | 2004-06-23 | 2006-01-26 | Lanxess Deutschland Gmbh | Herstellung von fluorierten 1,3-Benzodioxanen |
| AR059733A1 (es) | 2006-03-07 | 2008-04-23 | Smithkline Beecham Corp | Compuesto derivado de glicina n- sustituida con heteroaromaticos bicicicos, composicion farmaceutica que lo comprende, uso para preparar un medicamento para tratar la anemia y proceso para su preparacion |
| KR101495611B1 (ko) * | 2006-04-07 | 2015-02-25 | 메틸진 인코포레이티드 | 히스톤 데아세틸라아제의 억제제 |
| US7898712B2 (en) | 2008-06-27 | 2011-03-01 | Lockheed Martin Corporation | Risley integrated steering module |
| GB201112607D0 (en) | 2011-07-22 | 2011-09-07 | Glaxo Group Ltd | Novel compounds |
| EP2701699B1 (en) * | 2011-04-28 | 2019-10-16 | The Broad Institute, Inc. | Inhibitors of histone deacetylase |
| WO2013143597A1 (en) * | 2012-03-29 | 2013-10-03 | Glaxo Group Limited | Demethylase enzymes inhibitors |
| WO2014089368A1 (en) | 2012-12-05 | 2014-06-12 | Bio-Rad Laboratories, Inc | Methods for polymerase chain reaction copy number variation assays |
| EP2928471B1 (en) * | 2012-12-06 | 2020-10-14 | Celgene Quanticel Research, Inc. | Histone demethylase inhibitors |
| US8969343B2 (en) * | 2012-12-19 | 2015-03-03 | Quanticel Pharmaceuticals, Inc. | Histone demethylase inhibitors |
| WO2014100818A1 (en) | 2012-12-21 | 2014-06-26 | Quanticel Pharmaceuticals, Inc. | Histone demethylase inhibitors |
| AR100997A1 (es) | 2014-06-25 | 2016-11-16 | Quanticel Pharmaceuticals Inc | Derivados de piridina como inhibidores de histona demetilasa |
| US20200039938A1 (en) * | 2017-03-30 | 2020-02-06 | Albert-Ludwigs-University Freiburg | Kdm4 inhibitors |
-
2015
- 2015-06-25 AR ARP150102042A patent/AR100997A1/es not_active Application Discontinuation
- 2015-06-25 PT PT158115238T patent/PT3160952T/pt unknown
- 2015-06-25 EA EA201692483A patent/EA031200B1/ru unknown
- 2015-06-25 LT LTEP15811523.8T patent/LT3160952T/lt unknown
- 2015-06-25 HU HUE15811523A patent/HUE053876T2/hu unknown
- 2015-06-25 WO PCT/US2015/037812 patent/WO2015200709A1/en not_active Ceased
- 2015-06-25 PL PL15811523T patent/PL3160952T3/pl unknown
- 2015-06-25 KR KR1020177002223A patent/KR102591897B1/ko active Active
- 2015-06-25 EP EP20184107.9A patent/EP3738960A1/en not_active Withdrawn
- 2015-06-25 CN CN201580045921.2A patent/CN106660982B/zh active Active
- 2015-06-25 ES ES15811523T patent/ES2862648T3/es active Active
- 2015-06-25 EP EP20184106.1A patent/EP3741749A1/en active Pending
- 2015-06-25 MX MX2016017407A patent/MX375219B/es active IP Right Grant
- 2015-06-25 US US14/751,007 patent/US9242968B2/en active Active
- 2015-06-25 TW TW104120633A patent/TWI715533B/zh active
- 2015-06-25 AU AU2015279719A patent/AU2015279719B2/en active Active
- 2015-06-25 NZ NZ728120A patent/NZ728120A/en unknown
- 2015-06-25 SG SG11201610813TA patent/SG11201610813TA/en unknown
- 2015-06-25 CA CA2953437A patent/CA2953437C/en active Active
- 2015-06-25 US US15/321,702 patent/US10385047B2/en active Active
- 2015-06-25 HR HRP20210299TT patent/HRP20210299T1/hr unknown
- 2015-06-25 TW TW109143458A patent/TWI758004B/zh active
- 2015-06-25 BR BR112016030367A patent/BR112016030367A2/pt not_active Application Discontinuation
- 2015-06-25 DK DK15811523.8T patent/DK3160952T3/da active
- 2015-06-25 SI SI201531524T patent/SI3160952T1/sl unknown
- 2015-06-25 EP EP15811523.8A patent/EP3160952B1/en active Active
- 2015-06-25 JP JP2016574454A patent/JP6521535B2/ja active Active
- 2015-06-25 CN CN202010813617.0A patent/CN111909083B/zh active Active
- 2015-12-09 US US14/963,754 patent/US9447046B2/en active Active
-
2016
- 2016-07-26 US US15/220,118 patent/US9586902B2/en active Active
- 2016-12-18 IL IL249629A patent/IL249629A0/en unknown
- 2016-12-22 SA SA516380585A patent/SA516380585B1/ar unknown
- 2016-12-22 CL CL2016003301A patent/CL2016003301A1/es unknown
-
2017
- 2017-01-09 US US15/402,100 patent/US9815828B2/en active Active
- 2017-01-16 CO CONC2017/0000359A patent/CO2017000359A2/es unknown
- 2017-01-24 EC ECIEPI20174931A patent/ECSP17004931A/es unknown
- 2017-10-24 US US15/792,570 patent/US9994561B2/en active Active
-
2018
- 2018-05-04 US US15/971,749 patent/US10106534B2/en active Active
-
2021
- 2021-03-01 CY CY20211100169T patent/CY1123906T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017523152A5 (oth) | ||
| JP2017519781A5 (oth) | ||
| RU2019131111A (ru) | ПРОИЗВОДНОЕ ГЕТЕРОАРИЛ[4,3-с]ПИРИМИДИН-5-АМИНА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКИЕ ПРИМЕНЕНИЯ | |
| JP2017527561A5 (oth) | ||
| WO2015132799A3 (en) | Heterocyclic compounds | |
| JP2021524838A5 (oth) | ||
| JP2016516699A5 (oth) | ||
| JP2017502940A5 (oth) | ||
| JP2016514159A5 (oth) | ||
| CY1120248T1 (el) | Ενωσεις ιμιδαζο[4,5-c]κινολιν-2-ονης και η χρηση τους στη θεραπευτικη αντιμετωπιση του καρκινου | |
| EA201700077A1 (ru) | Соединения аминопиримидинила в качестве ингибиторов jak | |
| EA201992128A1 (ru) | Конденсированные имидазопиперидиновые ингибиторы jak | |
| JP2018519343A5 (oth) | ||
| CY1119727T1 (el) | Ενωσεις και συνθεσεις για τη θεραπεια παρασιτικων νοσων | |
| JP2016540742A5 (oth) | ||
| JP2016513137A5 (oth) | ||
| JP2009263394A5 (oth) | ||
| HK1243930A1 (zh) | 作爲fxr/tgr5激动剂的胆汁酸类似物和其使用方法 | |
| EA201491672A1 (ru) | Гетероциклильные соединения как ингибиторы mek | |
| NZ703064A (en) | Inhibitors of hepatitis c virus | |
| EA201650029A1 (ru) | Пиразолопиридины и пиразолопиримидины | |
| CA2864222A1 (en) | Cycloalkane derivative | |
| JP2012513416A5 (oth) | ||
| JP2020502092A5 (oth) | ||
| EA201691136A1 (ru) | Производное на основе 1,2-нафтохинона и способ его получения |